A few months after the American Chemical Society won its lawsuit against the pirate site, the game of virtual whack-a-mole continues.
The Scientist is bringing together a panel of experts to discuss the value of spheroid culture systems, and to explore the technical benefits and challenges of making the switch from 2-D to 3-D culture.
August 4, 2017|
High attrition in clinical trials and the need to replace animal models in a variety of applications has driven researchers to develop in vitro assays with greater physiological relevance. The last decade has seen a large variety of models developed to mimic cells organized into tissues and even organs. These have collectively been termed 3-D cell culture models. 3-D methods are deemed superior to growing cells in a monolayer due to increased extracellular matrix (ECM) formation, cell-to-cell and cell-to-matrix interactions, all important for differentiation, proliferation and cellular functions in vivo. Currently, the most popular method of 3-D cell culture is aggregating cells into spheroids. The Scientist is bringing together a panel of experts to discuss the value of spheroid culture systems, and to explore the technical benefits and challenges of making the switch from 2-D to 3-D culture. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.
Topics to be covered:
Esmaiel Jabbari, PhD
Professor, Chemical Engineering, Biomedical Engineering
College of Engineering and Computing, University of South Carolina
Margaret Magdesian, PhD
Founder and CEO